Concord Medical Files 2023 Annual Report on Form 20-F
Concord Medical Files 2023 Annual Report on Form 20-F
BEIJING, April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at and on the SEC's website at www.sec.gov. Shareholders may receive a hard copy of the Annual Report free of charge upon request. Requests should be submitted to
北京，2024年4月19日 /PRNewswire/ — 中國專門從事癌症治療、研究、教育和預防的醫療保健提供商康科德醫療服務控股有限公司（“協和醫療” 或 “公司”）（紐約證券交易所代碼：CCM）今天宣佈，已向美國證券交易委員會提交了截至2023年12月31日財年的20-F表年度報告（“年度報告”）。年度報告的電子副本可在康科德醫療的投資者關係網站和美國證券交易委員會的網站上訪問 www.sec.gov。股東可以根據要求免費獲得年度報告的紙質副本。請求應提交至
About Concord Medical
關於康科德醫療
Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China. For more information, please see .
康科德醫療服務控股有限公司是一家醫療保健提供商，提供包括癌症診斷、治療、教育和預防在內的全週期優質腫瘤學服務。該公司專注於在癌症醫院腫瘤醫療服務的各個方面提供多學科癌症護理，併爲其配備技術先進的設備，例如最先進的質子治療系統。該公司正在努力通過其自有癌症醫院和診所網絡以及中國各地的合作醫院來提高癌症治療的質量和可及性。欲了解更多信息，請參閱 。
Safe Harbor Statement
安全港聲明
This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
本公告包含前瞻性陳述。這些前瞻性陳述可以通過諸如 “將”、“期望”、“預期”、“未來”、“打算”、“計劃”、“相信”、“估計” 等詞語或短語來識別。前瞻性陳述本質上受公司無法控制的不確定性和突發事件的影響，並以未來業務決策的前提爲基礎，這些決策可能會發生變化。許多重要因素可能導致實際業績與任何前瞻性陳述中包含的結果存在重大差異。除非適用法律要求，否則公司不承擔任何更新任何前瞻性陳述的義務。
SOURCE Concord Medical Services Holdings Limited
來源 Concord 醫療服務控股有限公司
譯文內容由第三人軟體翻譯。